Document Detail


Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome.
MedLine Citation:
PMID:  8793173     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A dilemma must be faced when deciding whether or not to use thrombolytic therapy in patients with acute myocardial infarction and circulating antiphospholipid antibody. This report is about a patient whose infarct-related coronary artery was successfully revascularized by recombinant tissue plasminogen activator without any major bleeding complications. The nature of the infarct-related artery was described by the use of intravascular ultrasonography.
Authors:
Y L Ho; M F Chen; C C Wu; W J Chen; Y T Lee
Related Documents :
8804773 - Immediate hemodynamic effects of thrombolytic therapy on the ischemic myocardium.
2397723 - Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cardiology     Volume:  87     ISSN:  0008-6312     ISO Abbreviation:  Cardiology     Publication Date:    1996 Jul-Aug
Date Detail:
Created Date:  1996-11-13     Completed Date:  1996-11-13     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1266406     Medline TA:  Cardiology     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  354-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine (Cardiology), National Taiwan University Hospital, Taipei.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiphospholipid Syndrome / complications*,  diagnosis
Coronary Angiography
Electrocardiography
Humans
Male
Middle Aged
Myocardial Infarction / complications,  diagnosis,  drug therapy*
Plasminogen Activators / therapeutic use*
Recombinant Proteins
Thrombolytic Therapy / methods*
Tissue Plasminogen Activator / therapeutic use*
Ultrasonography, Interventional
Chemical
Reg. No./Substance:
0/Recombinant Proteins; EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Left ventricular systolic and diastolic function in severe obesity: a radionuclide study.
Next Document:  Atypical electrocardiogram and echocardiogram in a patient with Bland-White-Garland syndrome in asso...